Welcome to hospitalpharma.com

HospitalPharma.com today | 09 February 2010

GSK launches new rare diseases unit

GSK recently announced the formation of a new standalone unit specialising in the development and commercialisation of medicines for rare diseases.

Over 5,500 rare diseases have been identified of which less than 10% are currently being treated, presenting a significant unmet medical need. Despite the rarity of each condition, the number of diseases means that between 6-8% of the population may be affected by a rare disease. Many are genetic in origin, start in childhood and cause lifelong debility and premature death.

Operating under a lean structure, Marc Dunoyer, GSK's President of Asia Pacific and Chairman of Japan, will lead this new operation, working closely with Patrick Vallance, GSK’s Senior Vice President of Drug Discovery. The new unit will seek to leverage existing capabilities and partnerships and establish further in-licensing opportunities.

more HospitalPharma.com today stories

Breaking Drug Discovery Articles

Click the 'more' link below to be taken to the latest journal article entries in the area of drug discovery, provided by http://www.leaddiscovery.co.uk.

Latest Features

How to use RSS to get a pharma job
27 Jan 10
RSS is a much under-estimated and under-used thing.

Haiti Aid
27 Jan 10
At 16:53 local time on Tuesday, 12 January 2010, the small Caribbean island nation of Haiti was dealt another cruel blow: a massive 7.

Alzheimer’s - An Overview
21 Jan 10
Hardly a week goes by without Alzheimer’s being in the news – scientists discovering more about what causes it, developing a greater idea of how we can prevent or treat it, or another step being taken...

Latest Poll

CPD - How important is it?